Caimi et al 1 reported that patients with acute myocardial infarction (MI) at an age of 45 years showed a higher plasma viscosity (PV) compared with control participants. Plasma viscosity was similar between patient subgroups when stratified according to the type of MI, number of cardiovascular (CV) risk factors, and degree and extent of coronary artery stenosis. However, PV was significantly higher in patients with higher neutrophil to lymphocyte ratio (NLR). During a median follow-up period of 18 months, they found that PV persisted to be high at 3-and 12-month visits, despite a higher rate of optimal medications. Plasma viscosity on admission was also significantly higher in patients with CV complications during follow-up.
Increased blood viscosity is significantly associated with several CV risk factors and adverse CV outcomes. [2] [3] [4] Although Caimi et al 1 present pathophysiological explanations for the development of MI in younger patients, the results should be interpreted in the light of some limitations. It was previously reported that younger healthy male participants have higher blood viscosity compared with younger healthy female participants, which has been attributed to hormonal differences. 5 As the majority of patients (90.8%) in the study of Caimi et al 1 were males, the authors should comment on the possible impact of gender on study outcomes. Another interesting finding by Caimi et al 1 was the similarity for the number of CV risk factors and the degree/extent of coronary artery stenosis between groups, but PV was higher in patients with higher NLR and poor CV outcomes. We reported that patients with coronary slow flow had a higher whole blood viscosity. 2 Therefore, the authors may calculate the ''Thrombolysis In Myocardial Infarction'' frame counts for their study population and comment on the possible relationship of coronary slow flow with the NLR and poor CV outcomes in their study groups. Furthermore, the rate of statin (75.31%) and b-blocker (64.45%) use at hospital discharge was relatively low for such high-risk patients. The authors should comment on the possible adverse impact of the lower rate of such drug use. 6 
